EIC Summit 25 Networking Platform

2–3 Apr 2025 | Brussels, Belgium

InvestmentUpdated on 20 March 2025

GENBIOMA SERIES A

Josune Ayo

CoFounder & CEO at Genbioma Aplicaciones S.L.

Navarra, Navarra, Spain

About

Funding type: Series A. Venture capital firms, strategic partners, and other institutional investors

Technology: Microbiome Science.

Platform to develop POSTBIOTICS as ingredients and nutritional supplements that regulate metabolism through the balance of the intestinal microbiota.

Our cutting-edge technology is based on the platform in C. elegans to quickly search new strains for metabolic disorders by targeting the gut microbiota. Inactivated strains for developing effective, safe and highly stable Postbiotics for Metabolic Health.

Therapeutic Area: Preventing Metabolic Disorders. Our first portfolio of microbiome solutions for people with type 2 diabetes, prediabetes and obesity. Postbiotic products to prevent and reverse disease progression.

Stage

  • Expansion
  • Growth and Establishment

Organisation

Genbioma Aplicaciones S.L.

Start-ups and SMEs

Navarra, Spain

Similar opportunities